» Articles » PMID: 30767102

Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers

Overview
Publisher Springer
Specialty Public Health
Date 2019 Feb 16
PMID 30767102
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To examine smoking and use of smoking cessation aids among tobacco-associated cancer (TAC) or non-tobacco-associated cancer (nTAC) survivors. Understanding when and if specific types of cessation resources are used can help with planning interventions to more effectively decrease smoking among all cancer survivors, but there is a lack of research on smoking cessation modalities used among cancer survivors.

Methods: Kentucky Cancer Registry data on incident lung, colorectal, pancreatic, breast, ovarian, and prostate cancer cases diagnosed 2007-2011, were linked with health administrative claims data (Medicaid, Medicare, private insurers) to examine the prevalence of smoking and use of smoking cessation aids 1 year prior and 1 year following the cancer diagnosis. TACs included colorectal, pancreatic, and lung cancers; nTAC included breast, ovarian, and prostate cancers.

Results: There were 10,033 TAC and 13,670 nTAC survivors. Smoking before diagnosis was significantly higher among TAC survivors (p < 0.0001). Among TAC survivors, smoking before diagnosis was significantly higher among persons who: were males (83%), aged 45-64 (83%), of unknown marital status (84%), had very low education (78%), had public insurance (89%), Medicaid (85%) or were uninsured (84%). Smoking cessation counseling and pharmacotherapy were more common among TAC than nTAC survivors (p < 0.01 and p = 0.05, respectively).

Discussion: While smoking cessation counseling and pharmacotherapy were higher among TAC survivors, reducing smoking among all cancer survivors remains a priority, given cancer survivors are at increased risk for subsequent chronic diseases, including cancer. Tobacco cessation among all cancer survivors (not just those with TAC) can help improve prognosis, quality of life and reduce the risk of further disease. Health care providers can recommend for individual, group and telephone counseling and/or pharmacotherapy recommendations. These could also be included in survivorship care plans.

Citing Articles

Dysphagia, nutritional status, and quality of life in patients with head and neck cancer undergoing radiotherapy alone or combined with chemotherapy: an observational study.

Gomes M, Ferreira P, Almeida A, Cornelio J, Arruda T, Mafra A BMC Cancer. 2025; 25(1):416.

PMID: 40055649 PMC: 11887319. DOI: 10.1186/s12885-025-13695-y.


Passive smoking and risk of pancreatic cancer: an updated systematic review and meta-analysis.

Wang X, Wang Z, Wang X PeerJ. 2024; 12:e18017.

PMID: 39399427 PMC: 11468807. DOI: 10.7717/peerj.18017.


Pulmonary and Cardiac Smoking-Related History Improves Abstinence Rates in an Urban, Socioeconomically Disadvantaged Patient Population.

Khera Z, Illenberger N, Sherman S J Gen Intern Med. 2024; .

PMID: 39358497 DOI: 10.1007/s11606-024-09071-4.


Smoking cessation counselling patterns in cancer patients - survey of Lebanese physicians.

Najdi J, El Hawa M, El-Achkar A, Naji N, Telvizian T, Romani M Ecancermedicalscience. 2024; 18:1699.

PMID: 38774569 PMC: 11108051. DOI: 10.3332/ecancer.2024.1699.


Improving referral rates for smoking cessation: A multifaceted intervention aimed at radiation oncologists.

Bronsema I, van Lonkhuijzen L, Scholten P, Laan J, Westerveld H, Stalpers L Tech Innov Patient Support Radiat Oncol. 2024; 29:100225.

PMID: 38173986 PMC: 10761906. DOI: 10.1016/j.tipsro.2023.100225.


References
1.
Goldstein A, Ripley-Moffitt C, Pathman D, Patsakham K . Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers. Nicotine Tob Res. 2012; 15(1):52-8. PMC: 3842130. DOI: 10.1093/ntr/nts083. View

2.
Shiels M, Gibson T, Sampson J, Albanes D, Andreotti G, Beane Freeman L . Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol. 2014; 32(35):3989-95. PMC: 4251962. DOI: 10.1200/JCO.2014.56.8220. View

3.
Tyc V, Lensing S, Klosky J, Rai S, Robinson L . A comparison of tobacco-related risk factors between adolescents with and without cancer. J Pediatr Psychol. 2005; 30(4):359-70. DOI: 10.1093/jpepsy/jsi030. View

4.
Polednak A . Obtaining smoking histories for population-based studies on multiple primary cancers: Connecticut, 2002. Int J Cancer. 2006; 119(1):233-5. DOI: 10.1002/ijc.21786. View

5.
Kawahara M, Ushijima S, Kamimori T, Kodama N, Ogawara M, Matsui K . Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer. 1998; 78(3):409-12. PMC: 2063017. DOI: 10.1038/bjc.1998.507. View